Themis Medicare Limited

Themis Medicare Limited

Themis Medicare Limited has informed the Exchange about the resignation of a Director/KMP/SMP.

Themis Medicare Limited

Themis Medicare Limited has submitted its Investor Presentation for Q1 FY27, highlighting a strong improvement in bottom-line performance with Profit Before Tax (PBT) at ₹38.6 crore compared to a loss of ₹14.1 crore in Q1 FY26. The Company reported a healthy PAT margin of 28.3%.

Themis Medicare Limited

Themis Medicare Limited has informed the Exchange about General Updates, disclosing authorized persons to determine materiality of an event or information and make disclosures to stock exchange(s).

Themis Medicare Limited

Themis Medicare Limited has informed the Exchange regarding the appointment of Mr. Suresh Savaliya as Company Secretary & Compliance Officer of the company, effective August 13, 2026. The appointment is in place of Mr. Nagraj Mogaveera, who has resigned from the position due to transitioning into a different role within the Company.

Themis Medicare Limited

Themis Medicare Limited has informed the Exchange regarding Resignation of Mr. Nagraj Mogaveera as Company Secretary & Compliance Officer of the company w.e.f. August 13, 2026. The Board of Directors have approved the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer & Key Managerial Personnel (KMP) of the company in place of Mr. Nagraj Mogaveera.

Themis Medicare Limited

Themis Medicare Limited has submitted unaudited standalone and consolidated financial results for the period ended June 30, 2026. The Board of Directors has also approved the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer and the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer & Key Managerial Personnel (KMP).

Themis Medicare Limited

Themis Medicare Limited has informed the Exchange about Certificate under 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.

Themis Medicare Limited

Themis Medicare Limited has informed the Exchange regarding the closure of the trading window due to the declaration of un-audited financial results for the quarter ending 30th June, 2026.

Themis Medicare Limited

Themis Medicare Limited responded to NSE's query concerning a significant spurt in its share trading volume and price. The company clarified that there is no pending or delayed disclosure of any material information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. They affirmed that all relevant information is regularly disseminated, indicating that the recent market activity is not attributable to any undisclosed corporate development.

Themis Medicare Limited

The National Stock Exchange (NSE) has observed a significant increase in the trading volume of Themis Medicare Limited shares. To ensure market transparency and safeguard investor interests, the Exchange has formally requested clarification from the company regarding the reasons for this unusual activity. Themis Medicare's response to this inquiry is currently pending.